Soonju Park

1.2k total citations · 1 hit paper
10 papers, 573 citations indexed

About

Soonju Park is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Soonju Park has authored 10 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 3 papers in Hepatology. Recurrent topics in Soonju Park's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (5 papers) and Influenza Virus Research Studies (3 papers). Soonju Park is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (5 papers) and Influenza Virus Research Studies (3 papers). Soonju Park collaborates with scholars based in South Korea, Norway and Estonia. Soonju Park's co-authors include David Shum, Seungtaek Kim, Soo Young Byun, Sangeun Jeon, Jihye Lee, Meehyun Ko, Inhee Choi, Eunji Jo, Ji Yeun Kim and So Yun Lim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Soonju Park

10 papers receiving 568 citations

Hit Papers

Identification of Antiviral Drug Candidates against SARS-... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soonju Park South Korea 8 377 121 116 102 51 10 573
Julie Blaising France 7 305 0.8× 130 1.1× 45 0.4× 195 1.9× 73 1.4× 8 638
Gitanjali Subramanya United States 7 438 1.2× 114 0.9× 62 0.5× 231 2.3× 71 1.4× 8 793
Jakob J Malin Germany 10 288 0.8× 119 1.0× 42 0.4× 68 0.7× 67 1.3× 25 479
Emma Woolner Canada 4 682 1.8× 207 1.7× 135 1.2× 72 0.7× 95 1.9× 6 847
Carina Elsner Germany 11 201 0.5× 107 0.9× 37 0.3× 91 0.9× 35 0.7× 21 510
Anushka C. Galasiti Kankanamalage United States 14 593 1.6× 147 1.2× 187 1.6× 63 0.6× 13 0.3× 19 794
Zhiwei Xie China 13 345 0.9× 118 1.0× 31 0.3× 163 1.6× 109 2.1× 35 607
Thi-Tuyet-Nhung Le France 7 610 1.6× 254 2.1× 112 1.0× 89 0.9× 40 0.8× 14 811
André C. Ferreira Brazil 11 297 0.8× 194 1.6× 84 0.7× 69 0.7× 80 1.6× 19 584
Kirstin Mösbauer Germany 5 397 1.1× 197 1.6× 72 0.6× 150 1.5× 75 1.5× 5 681

Countries citing papers authored by Soonju Park

Since Specialization
Citations

This map shows the geographic impact of Soonju Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soonju Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soonju Park more than expected).

Fields of papers citing papers by Soonju Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soonju Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soonju Park. The network helps show where Soonju Park may publish in the future.

Co-authorship network of co-authors of Soonju Park

This figure shows the co-authorship network connecting the top 25 collaborators of Soonju Park. A scholar is included among the top collaborators of Soonju Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soonju Park. Soonju Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Alberca, Lucas N., Carolina L. Bellera, Soonju Park, et al.. (2023). Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease. SHILAP Revista de lepidopterología. 2. 5 indexed citations
2.
Kim, Dong‐In, Soonju Park, Paul Kim, et al.. (2022). Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19. Vaccines. 10(11). 1864–1864. 6 indexed citations
4.
Lim, So Yun, Ji Yeun Kim, Soonju Park, et al.. (2021). Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination. Immune Network. 21(6). e41–e41. 8 indexed citations
5.
Kim, Ji Yeun, Seongman Bae, Soonju Park, et al.. (2021). Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines. Immune Network. 21(4). e29–e29. 12 indexed citations
6.
Yang, Jaewon, Alexander König, Soonju Park, et al.. (2021). A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals. JHEP Reports. 3(4). 100296–100296. 8 indexed citations
7.
Kim, Ji Yeun, So Yun Lim, Soonju Park, et al.. (2021). Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period. The Journal of Infectious Diseases. 225(5). 777–784. 15 indexed citations
8.
Jeon, Sangeun, Meehyun Ko, Jihye Lee, et al.. (2020). Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrobial Agents and Chemotherapy. 64(7). 450 indexed citations breakdown →
9.
Jo, Eunji, Dong-Kyun Ryu, Alexander König, et al.. (2020). Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor. Antiviral Research. 175. 104709–104709. 9 indexed citations
10.
König, Alexander, Jaewon Yang, Eunji Jo, et al.. (2019). Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells. Journal of Hepatology. 71(2). 289–300. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026